Leonard Saltz Selected Research

Proctectomy

5/2010	ACR Appropriateness Criteria: local excision in early-stage rectal cancer.
3/2006	Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.
8/2005	Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?
1/2003	Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leonard Saltz Research Topics

Disease

44	Colorectal Neoplasms (Colorectal Cancer) 12/2024 - 03/2004
44	Neoplasms (Cancer) 02/2024 - 04/2002
21	Rectal Neoplasms (Rectal Cancer) 12/2023 - 07/2002
14	Colonic Neoplasms (Colon Cancer) 12/2024 - 10/2002
11	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2003
5	Adenocarcinoma 03/2006 - 03/2004
4	Carcinoma (Carcinomatosis) 01/2023 - 08/2003
4	Neutropenia 01/2021 - 04/2002
4	Exanthema (Rash) 10/2009 - 05/2005
3	Disease Progression 02/2024 - 01/2011
3	Fatigue 01/2023 - 05/2005
3	Diarrhea 01/2023 - 05/2005
2	Residual Neoplasm 12/2024 - 11/2004
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023 - 01/2019
2	Nausea 01/2023 - 01/2021
2	Vomiting 01/2023 - 01/2021
2	Microsatellite Instability 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 12/2017 - 12/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2013 - 01/2011
1	Sarcoidosis (Schaumann Disease) 02/2024
1	Inflammation (Inflammations) 02/2024
1	Deglutition Disorders (Dysphagia) 01/2023
1	Mucositis 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Edema (Dropsy) 01/2023
1	Constipation 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Pain (Aches) 01/2022
1	COVID-19 01/2021
1	Leukopenia 01/2021
1	Infections 01/2021
1	Cholangiocarcinoma 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Hypoxia (Hypoxemia) 01/2015

Drug/Important Bio-Agent (IBA)

12	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2004
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2003
10	Cetuximab (Erbitux)FDA Link 06/2012 - 08/2005
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2003
8	Bevacizumab (Avastin)FDA Link 12/2018 - 07/2008
7	Biomarkers (Surrogate Marker)IBA 12/2024 - 05/2005
6	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2005
4	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
4	Leucovorin (Folinic Acid)FDA Link 02/2013 - 07/2004
3	DNA (Deoxyribonucleic Acid)IBA 12/2024 - 01/2017
3	Carcinoembryonic AntigenIBA 03/2018 - 07/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017 - 03/2016
2	Trinitrotoluene (TNT)IBA 01/2022 - 04/2019
2	Calcibiotic Root Canal SealerIBA 01/2020 - 01/2019
2	Floxuridine (FUdR)FDA LinkGeneric 01/2020 - 02/2013
2	Angiogenesis InhibitorsIBA 01/2019 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2019 - 03/2016
2	VemurafenibIBA 04/2018 - 12/2015
2	BilirubinIBA 01/2018 - 05/2005
2	MicroRNAs (MicroRNA)IBA 03/2017 - 01/2015
2	Panitumumab (Vectibix)FDA Link 06/2011 - 07/2008
2	Growth Factor ReceptorsIBA 10/2005 - 08/2005
2	alvocidib (flavopiridol)IBA 05/2005 - 04/2002
1	Tumor Biomarkers (Tumor Markers)IBA 02/2024
1	pembrolizumabIBA 02/2024
1	lanreotide (Somatuline)FDA Link 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Gemcitabine FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Unsaturated FatsIBA 10/2018
1	Dietary Fats (Dietary Fat)IBA 10/2018
1	FatsIBA 10/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2018
1	1- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamideIBA 10/2018
1	AlbuminsIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	LigandsIBA 01/2018
1	Sodium Glutamate (Accent)IBA 11/2016
1	EnzymesIBA 02/2016
1	Oxygen (Dioxygen)IBA 02/2016
1	Glutathione (Reduced Glutathione)IBA 02/2016
1	AntioxidantsIBA 02/2016
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	APTO-253IBA 10/2015
1	Phosphocreatine (Neoton)IBA 01/2015
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2013

Therapy/Procedure

42	Therapeutics 02/2024 - 07/2002
27	Drug Therapy (Chemotherapy) 02/2021 - 07/2002
11	Neoadjuvant Therapy 12/2023 - 12/2005
8	Combined Modality Therapy 07/2012 - 01/2003
7	Radiotherapy 10/2022 - 03/2004
6	Adjuvant Chemotherapy 12/2024 - 10/2002
4	Proctectomy 05/2010 - 01/2003
3	Immunotherapy 02/2024 - 01/2019
2	Induction Chemotherapy 01/2022 - 04/2019
1	Aftercare (After-Treatment) 01/2023
1	Injections 01/2022
1	Colectomy 10/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Hepatectomy 03/2017
1	Ovariectomy (Oophorectomy) 01/2017
1	Continuity of Patient Care 07/2014